Page 2366 - Saunders Comprehensive Review For NCLEX-RN
P. 2366

15. Instruct the client to avoid alcohol or other CNS
                                                depressants, because these substances will allow more
                                                of the medication to enter the brain, causing feelings
                                                of depression and drowsiness, dizziness, slow and
                                                difficult breathing, confusion, and coma.
                                           16. Instruct the client to change positions slowly to avoid
                                                orthostatic hypotension.
                                           17. Instruct the client to report signs of agranulocytosis,
                                                including sore throat, fever, and malaise.
                                           18. Instruct the client to report signs of liver dysfunction,
                                                including jaundice, malaise, fever, and right upper
                                                abdominal pain.
                                           19. When discontinuing antipsychotics, the medication
                                                dosage should be reduced gradually to avoid sudden
                                                recurrence of psychotic symptoms.



                                                       Monitor for extrapyramidal side and adverse effects in the

                                                client taking an antipsychotic medication.

                            VIII. Neuroleptic Malignant Syndrome

                                A. Description
                                             1. A potentially fatal syndrome that may occur at any
                                                time during therapy with neuroleptic (antipsychotic)
                                                medications (typically with first generation
                                                antipsychotics).
                                             2. Although rare, neuroleptic malignant syndrome more
                                                commonly occurs at the initiation of therapy, after the
                                                client has changed from one medication to another,
                                                after a dosage increase, or when a combination of
                                                medications is used.
                                B. Assessment
                                             1. Dyspnea or tachypnea
                                             2. Tachycardia or irregular pulse rate
                                             3. Autonomic dysfunction
                                                             a. Hyperpyrexia
                                                             b. Hypertension
                                                             c. Tachycardia
                                                             d. Tachypnea
                                                             e. Diaphoresis
                                                             f. Drooling
                                             4. High or low blood pressure
                                             5. Excessive weakness or fatigue
                                             6. Altered level of consciousness
                                             7. Seizures
                                             8. Severe extrapyramidal side and adverse effects
                                             9. Skeletal muscle rigidity



                                                         2366
   2361   2362   2363   2364   2365   2366   2367   2368   2369   2370   2371